The incidence of brain metastases in human epidermal growth factor 2 (HER2)-positive and triple-negative breast cancers ranges from 30% to 55% and 25% to 46%, respectively, and HER2-positive breast cancers have the highest incidence of brain metastases. Here, ERBB2 is linked to triple-negative breast carcinoma.